Abstract
Patients with heart failure (HF) are at an increased risk of stroke, sudden death and venous thromboembolism, which are all linked to thrombus formation (thrombogenesis). The present 'viewpoint' article will discuss how the prothrombotic state in HF may be perpetuated by a chronic inflammatory state that is maladaptive. Indeed, there is considerable evidence that thrombogenesis and endothelial (dys)function can be intimately linked to inflammation in HF.
MeSH terms
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Endothelium / physiopathology
-
Heart Failure / drug therapy
-
Heart Failure / etiology
-
Heart Failure / physiopathology*
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
-
Inflammation / drug therapy*
-
Inflammation / physiopathology
-
Risk Factors
-
Thromboembolism / complications
-
Thromboembolism / physiopathology*
Substances
-
Angiotensin-Converting Enzyme Inhibitors
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors